482 related articles for article (PubMed ID: 22679906)
1. Prognostic indicators of survival in patients with compensated and decompensated cirrhosis.
Zipprich A; Garcia-Tsao G; Rogowski S; Fleig WE; Seufferlein T; Dollinger MM
Liver Int; 2012 Oct; 32(9):1407-14. PubMed ID: 22679906
[TBL] [Abstract][Full Text] [Related]
2. [Measurement of hepatic venous pressure gradient in liver cirrhosis: relationship with the status of cirrhosis, varices, and ascites in Korea].
Kim MY; Baik SK; Suk KT; Yea CJ; Lee IY; Kim JW; Cha SH; Kim YJ; Um SH; Han KH
Korean J Hepatol; 2008 Jun; 14(2):150-8. PubMed ID: 18617762
[TBL] [Abstract][Full Text] [Related]
3. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis.
Ripoll C; Groszmann R; Garcia-Tsao G; Grace N; Burroughs A; Planas R; Escorsell A; Garcia-Pagan JC; Makuch R; Patch D; Matloff DS; Bosch J;
Gastroenterology; 2007 Aug; 133(2):481-8. PubMed ID: 17681169
[TBL] [Abstract][Full Text] [Related]
4. New concepts on the clinical course and stratification of compensated and decompensated cirrhosis.
D'Amico G; Morabito A; D'Amico M; Pasta L; Malizia G; Rebora P; Valsecchi MG
Hepatol Int; 2018 Feb; 12(Suppl 1):34-43. PubMed ID: 28681347
[TBL] [Abstract][Full Text] [Related]
5. Prognostic markers in patients with cirrhosis and portal hypertension who have not bled.
Poca M; Puente A; Graupera I; Villanueva C
Dis Markers; 2011; 31(3):147-54. PubMed ID: 22045400
[TBL] [Abstract][Full Text] [Related]
6. Cardiopulmonary hemodynamics and C-reactive protein as prognostic indicators in compensated and decompensated cirrhosis.
Turco L; Garcia-Tsao G; Magnani I; Bianchini M; Costetti M; Caporali C; Colopi S; Simonini E; De Maria N; Banchelli F; Rossi R; Villa E; Schepis F
J Hepatol; 2018 May; 68(5):949-958. PubMed ID: 29331339
[TBL] [Abstract][Full Text] [Related]
7. The portal hypertension syndrome: etiology, classification, relevance, and animal models.
Bosch J; Iwakiri Y
Hepatol Int; 2018 Feb; 12(Suppl 1):1-10. PubMed ID: 29064029
[TBL] [Abstract][Full Text] [Related]
8. Classification of cirrhosis: the clinical use of HVPG measurements.
Albilllos A; Garcia-Tsao G
Dis Markers; 2011; 31(3):121-8. PubMed ID: 22045397
[TBL] [Abstract][Full Text] [Related]
9. Impact of sarcopenia on prognostic value of cirrhosis: going beyond the hepatic venous pressure gradient and MELD score.
Kang SH; Jeong WK; Baik SK; Cha SH; Kim MY
J Cachexia Sarcopenia Muscle; 2018 Oct; 9(5):860-870. PubMed ID: 30371017
[TBL] [Abstract][Full Text] [Related]
10. Hepatic venous pressure gradient measurement in patients with liver cirrhosis: a correlation with disease severity and variceal bleeding.
Silkauskaite V; Pranculis A; Mitraite D; Jonaitis L; Petrenkiene V; Kupcinskas L
Medicina (Kaunas); 2009; 45(1):8-13. PubMed ID: 19223700
[TBL] [Abstract][Full Text] [Related]
11. Hepatic Venous Pressure Gradient Predicts Long-Term Mortality in Patients with Decompensated Cirrhosis.
Kim TY; Lee JG; Sohn JH; Kim JY; Kim SM; Kim J; Jeong WK
Yonsei Med J; 2016 Jan; 57(1):138-45. PubMed ID: 26632394
[TBL] [Abstract][Full Text] [Related]
12. von Willebrand factor as new noninvasive predictor of portal hypertension, decompensation and mortality in patients with liver cirrhosis.
Ferlitsch M; Reiberger T; Hoke M; Salzl P; Schwengerer B; Ulbrich G; Payer BA; Trauner M; Peck-Radosavljevic M; Ferlitsch A
Hepatology; 2012 Oct; 56(4):1439-47. PubMed ID: 22532296
[TBL] [Abstract][Full Text] [Related]
13. Comparison of MELD, HVPG, and their changes to predict clinically relevant endpoints in cirrhosis.
Ripoll C; Lastra P; Rincón D; Catalina V; Bañares R
Scand J Gastroenterol; 2012 Feb; 47(2):204-11. PubMed ID: 22242615
[TBL] [Abstract][Full Text] [Related]
14. Short-term hemodynamic effects of β-blockers influence survival of patients with decompensated cirrhosis.
Alvarado-Tapias E; Ardevol A; Garcia-Guix M; Montañés R; Pavel O; Cuyas B; Graupera I; Brujats A; Vilades D; Colomo A; Poca M; Torras X; Guarner C; Concepción M; Aracil C; Torres F; Villanueva C
J Hepatol; 2020 Oct; 73(4):829-841. PubMed ID: 32298768
[TBL] [Abstract][Full Text] [Related]
15. Clinical Evaluation and Prognosis.
Hernández-Gea V; Berzigotti A
Dig Dis; 2015; 33(4):515-23. PubMed ID: 26159268
[TBL] [Abstract][Full Text] [Related]
16. Non-invasive aspartate aminotransferase to platelet ratio index correlates well with invasive hepatic venous pressure gradient in cirrhosis.
Kirnake V; Arora A; Sharma P; Goyal M; Chawlani R; Toshniwal J; Kumar A
Indian J Gastroenterol; 2018 Jul; 37(4):335-341. PubMed ID: 30178093
[TBL] [Abstract][Full Text] [Related]
17. Serum Albumin Can Identify Patients With Compensated Cirrhosis With a Good Prognosis.
Ripoll C; Bari K; Garcia-Tsao G
J Clin Gastroenterol; 2015 Aug; 49(7):613-9. PubMed ID: 25203362
[TBL] [Abstract][Full Text] [Related]
18. Comparison of hepatic venous pressure gradient and endoscopic grading of esophageal varices.
Lee E; Kim YJ; Goo DE; Yang SB; Kim HJ; Jang JY; Jeong SW
World J Gastroenterol; 2016 Mar; 22(11):3212-9. PubMed ID: 27003998
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of hepatic venous pressure gradient in patients with compensated chronic hepatitis C-related cirrhosis.
Rincón D; Lo Iacono O; Tejedor M; Hernando A; Ripoll C; Catalina MV; Salcedo M; Matilla A; Senosiain M; Clemente G; Molinero LM; Albillos A; Bañares R
Scand J Gastroenterol; 2013 Apr; 48(4):487-95. PubMed ID: 22871085
[TBL] [Abstract][Full Text] [Related]
20. Varices on computed tomography are surrogate of clinically significant portal hypertension and can predict survival in compensated cirrhosis patients.
Lee DH; Ahn JH; Chung JW; Kim YJ; Cha SW; Kim MY; Baik SK
J Gastroenterol Hepatol; 2019 Feb; 34(2):450-457. PubMed ID: 29900587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
